1 Oxidative mechanisms have been implicated in neonatal cardiomyocyte hypertrophy. We and others have shown that a HMG-CoA reductase inhibitor preserves endogenous antioxidant enzyme activity and inhibits cardiac hypertrophy in vivo. We therefore have examined whether noradrenaline (NA) induces the generation of reactive oxygen species (ROS) during its induction of neonatal cardiomyocyte hypertrophy and whether simvastatin, a HMG-CoA reductase inhibitor, attenuates ROS production and thus NA-induced hypertrophy of cardiomyocytes. 2 NA increased the intracellular ROS levels in a concentration-dependent manner. This increase of ROS was signi®cantly inhibited by simvastatin and catalase. Prazosin partially suppressed NAinduced increase of ROS and beating, while preincubation with both prazosin and propranolol completely abolished NA-evoked increase of ROS and beating. Simvastatin did not aect NAinduced increase of beating. 3 The NA-induced increase of protein content was partially suppressed by prazosin and completely abolished by preincubation with both prazosin and propranolol. Simvastatin inhibited the increase of NA-induced increase of RNA content and [ 4 We conclude that the inhibitory eects of simvastatin on myocyte hypertrophy were associated with its antioxidant eects and inhibition of MVA-metabolism pathway in neonatal rat cardiomyocytes. NA-induced increases of intracellular ROS and cardiomyocyte hypertrophy requires both a and b adrenoceptors activation in neonatal rat cardiomyocytes. The increases of ROS induced by NA is required for hypertrophy.
Introduction
Cardiac hypertrophy is an adaptive remodelling process of cardiomyocytes to haemodynamic overload from various causes. Unfortunately it is associated with an increased risk of arrhythmia (McLenachan et al., 1987) and development of congestive heart failure (Levy et al., 1990) . Therefore, the elucidation of the mechanisms leading to cardiac hypertrophy is important for preventing these harmful consequences.
Recent studies have shown that angiotensin II, tumour necrosis factor-a and ouabain stimulate the production of intracellular reactive oxygen species (ROS) in cultured rat neonatal cardiomyocytes (Nakamura et al., 1998; Xie et al., 1999) . The three stimuli induced ROS-dependent cardiomyocyte hypertrophy. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase have antioxidant eects (Suzumura et al., 1999; Yamamoto et al., 1998) and can preserve endogenous antioxidant enzyme activity in the aorta of rabbits fed a high cholesterol diet (Chen et al., 1997) . According to our previous results simvastatin, a HMG-CoA inhibitor, inhibits cardiac hypertrophy in rats with aortic stenosis (Luo et al., 1999a,b) . Taken together these results suggest that ROS may play an important role in signal transduction underlying the cardiomyocyte hypertrophy. Thus, we hypothesized that abnormal ROS accumulation caused by the hypertrophic factors leads to cardiomyocyte hypertrophy. Therefore, we have examined whether noradrenaline, an important cardiac hypertrophy promoting substance, induces hypertrophic growth of the rat neonatal cardiomyocytes via an intracellular signalling pathway involving ROS. We have also examined eects of simvastatin British Journal of Pharmacology (2001) 132, 159 ± 164 ã 2001 Nature Publishing Group All rights reserved 0007 ± 1188/01 $15.00 www.nature.com/bjp *Author for correspondence: E-mail: joluoa@public.guangzhou.gd.cn on NA-induced ROS production and hypertrophy of the cultured neonatal cardiomyocytes.
Methods

Materials
Simvastatin was purchased from Merck, Sharp & Dohme Co (Hangzhou, China). Because cardiomyocytes lack lactonases to process simvastatin to its active form, simvastatin was chemically activated before use as previously described (Blum, 1994; Gerson et al., 1989) . Transferrin, insulin, bromodeoxyuridine (BrdU), noradrenaline (NA), catalase, mevalonic acid, deoxyribonuclease (DNAase) I, prazosin, propranalol and 
Cell culture
Primary cultures of cardiomyocytes were prepared from the ventricles of neonatal Sprague-Dawley rats by the method of Simpson (1985) . After dissociation of the cardiac tissue with trypsin, cells were preplated for 2 h into 100-mm culture dishes in medium 199 with 10% FBS and maintained at 378C in humidi®ed air with 5% CO 2 to reduce the number of nonmyocyte cells. Cells that were not attached to the preplated dishes were plated onto 6-well culture plates (Corning) at a density of 1610 3 cells mm
72
. Non-myocytes on the cultures were limited to 10% of the total cell number by inclusion of BrdU (0.1 mmol l
71
) in the medium (Simpson, 1985) . The culture medium was replaced after 24 h with serum-free medium consisting of medium 199, transferring (10 mg ml ). On culture day 4, the myocytes were treated with NA, simvastatin, catalase, prazosin, propranalol or their diluent, as indicated.
Assessment of beating frequencies
Beating frequencies were visually recorded in each culture according to the method of Clark et al. (1991) . A random ®eld was selected near the centre of each culture and a typical rhythmically contracting cell was identi®ed. The elapsed time for 20 beats was determined with a stopwatch and converted to beats per minute. Beating was recorded on a daily basis in only a single ®eld of each culture. Multiple readings from the same culture could have produced biased estimates of beating frequencies due to the high degree of cell contact, and essentially identical rates were recorded from multiple cells from the same culture. If no contractions were observed in the randomly selected ®eld over a 30-s observation period, the culture was recorded as negative for beating.
Analysis of dichlorofluorescein fluorescence
The¯uorescent probe, 2',7'-dichloro¯uorescin diacetate (DCF-DA), was used for the assessment of intracellular ROS formation in cultured rat cardiomyocytes. This assay is a reliable method for the measurement of intracellular ROS such as hydrogen peroxide (H 2 O 2 ), hydroxyl radical, and hydroperoxides (Cathcart et al., 1983; Zhu et al., 1994 
Analysis of propidium iodide (PI) fluorescence
PI is a¯uorescent dye that can intercalate speci®cally into double-helical regions of both DNA and RNA. To apply this to RNA, we stained RNA with PI after DNA digestion with deoxyribonuclease (DNAase) I. PI does not stain total cellular RNA, but only that fraction of RNA that is in double-stranded conformation. This fraction can be de®ned as the RNA that binds intercalating dyes, and changes in the proportion of double-stranded RNA are related to the total RNA (Frankfurt, 1980) .
The cultured neonatal rat cardiac myocytes were treated with NA (20 mmol l 71 Tris-HCl (pH 6.5) for 40 min at 368C. After incubation with enzymes, 1 ml of Hanks' solution containing 0.05 mg ml 71 PI were added to each well and kept for 30 min before laser confocal microscopy analysis. Randomly selected 2 ®elds in each well were examined for each condition.
[
H]-leucine incorporation
To examine the inhibitory eects of simvastatin on myocyte protein synthesis induced by NA, the [ 3 H]-leucine incorporation was measured as described previously (Thaik et al., 1995) . Cultured myocytes were treated with NA (20 mmol l ), or diluent (control) from culture day 4 to 7. The cells were washed with Hanks' solution and scraped o the well and then treated with 5% trichloroacetic acid as described above. The precipitates were dissolved in NaOH (0.1 mol l 71 ). The protein content was measured by the Coomassie blue method (Khalid & Ashraf, 1993) .
Statistical analysis
For the comparison of group means, one-way ANOVA and Student-Newman-Keuls tests were used as appropriate. A Pvalue 50.05 was considered statistically signi®cant.
Results
Inhibitory effects of simvastatin on NA-induced increase of PI fluorescence
To determine whether simvastatin inhibited NA-induced RNA synthesis, cardiomyocytes treated with NA (20 mmol l
71
) and simvastatin (1 ± 1000 nmol l 71 ) for 3 days were incubated with PI. Simvastatin signi®cantly inhibited the NA-induced increase of DNAas-treated PI¯uorescence in a concentration-dependent manner compared with that in control cells ( Figure 1A ) partially inhibited increase of protein content evoked by NA respectively and preincubation with both prazosin and propranalol completely abolished the NAinduced increase of protein content in the cultured neonatal cardiomyocytes (Table 1) . These results suggested that NA induces cardiomyocyte hypertrophy through both a-and badrenergic stimulation. Simvastatin (1 ± 1000 nmol l ). NA signi®cantly increased DCF-DA¯uorescence in a concentration-dependent manner compared with that in controls ( Figure 3A,B) . NA-induced production of ROS was partially inhibited by prazosin (20 mmol l 
Effects of prazosin and propranolol on NA-induced beating
It has been shown that an increase in the beating rate of neonatal cardiomyocytes requires both a-and b-adrenoceptors activation. Recently, it has been reported that NA synergistically induces cardiomyocyte hypertrophy through both a-and b-adrenergic stimulation (Yamazaki et al., 1997) . To evaluate the role of beating in NA-induced neonatal rat cardiomyocyte hypertrophy, we preincubated cardiomyocytes with prazosin (20 mmol l 71 ), and/or propranalol (20 mmol l 71 ) for 10 min and then exposed cardiomyocytes to NA (20 mmol l 71 ) for 3 min. Prazosin and propranolol each partially suppressed NA-induced increase of beating, and preincubation with both prazosin and propranolol completely abolished the NA-evoked increase of beating rate. There were no eects of simvastatin (1000 nmol l 71 ) on increase of beating induced by NA (Table 1) .
Discussion
The present study for the ®rst time showed that simvastatin can inhibit the NA-induced ROS production and hypertrophic reaction in the neonatal rat cardiomyocytes. MVA can reverse the antihypertrophic eects of simvastatin. These results suggest that simvastatin may inhibit neonatal rat cardiomyocytes hypertrophy through blocking the biosynthesis of MVA. MVA, an intracellular product of HMG-CoA reductase, is necessary for cell growth (Goldstein & Brown, 1990) . MVA metabolism yields a series of isoprenoid derivatives that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control (Goldstein & Brown, 1990; Raiteri et al., 1997) .
Another new ®nding of our work is that the NA-induced increase of ROS and hypertrophy requires a-and badrenoceptor activation. In cardiomyocytes, NA activates at least two types of receptors, a-and b-adrenoceptors. Simpson et al. (1983) reported that NA stimulates hypertrophy of cultured neonatal rat cardiomyocytes through a1-but not through b-adrenoceptors. They also showed that an increase in beating rate requires both a-and b-adrenoceptor activation. It has also been reported that b-adrenergic activation produces adult feline cardiomyocyte hypertrophy by activating the beating of cardiomyocytes (Clark et al., 1991) . Recently, Yamazaki et al. (1997) indicated that NA activates the raf-1 kinase/mitogen activated protein (MAP) kinase cascade through both a-and b-adrenergic stimulation, and signalling pathways from the two receptors synergistically induce cardiomyocyte hypertrophy. Our results presented here clearly show that blockade of a-and badrenoceptors partially inhibits the NA-induced increase of ROS, beating and protein content, whereas only combined inhibition yields complete inhibition. These results indicate that NA induces increase of ROS, beating and hypertrophy through both a-and b-adrenergic stimulation. Neither a-nor b-adrenoceptor stimulation alone can fully mediate the eects of NA. Our results also showed that NA-induced increases of ROS are required for hypertrophy in neonatal rat cardiomyocyte. This conclusion was supported by the following results. Firstly, we have shown that NA generates ROS and induces hypertrophic growth in a concentration-dependent manner in the cultured neonatal cardiomyocytes. Second, prazosin+ propranolol completely inhibited the increase of ROS and protein content in the cultured neonatal cardiomyocytes induced by NA. Third, catalase, an enzyme that speci®cally decomposes H 2 O 2 to water and molecular oxygen, inhibited the NA-induced increase of ROS, RNA content and [ 3 H]-leucine incorporation in cultured neonatal cardiomyocytes.
In summary, we have shown that the inhibitory eects of simvastatin on cardiomyocyte hypertrophy were associated with its antioxidant eects and inhibition of the MVAmetabolism pathway in neonatal rat cardiomyocytes. NAinduced increases of intracellular ROS and cardiomyocyte hypertrophy requires both a-and b-adrenoceptor activation in neonatal rat cardiomyocytes. The increases of ROS induced by NA is required for hypertrophy.
